FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a solid pharmaceutical composition. The composition comprises tegaserod or its salts as an active component that is sensitive to acid effect and/or difficultly soluble in water, and a loosening agent taken in the amount at least 15 wt.-% as measured for the total mass of the composition. The composition is stable and can be prepared easily, it shows good rate release after its administration patients and good biological availability. The composition is designated for prophylaxis, modulation or treatment of visceral pain or discomfort, for modulation of visceral sensitivity or perception, improvement of sensory perception of rectum intestine tension and for treatment of anal dysfunction regulation.
EFFECT: improved and valuable medicinal properties of composition.
14 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE MODIFICATIONS OF TEGASEROD HYDROMALEATE | 2004 |
|
RU2349585C2 |
| PHARMACEUTICAL COMPOSITIONS AND THEIR USING IN TREATMENT OF GASTROENTERIC DISEASES | 2000 |
|
RU2264215C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING PARTIAL 5HTAGONIST | 2002 |
|
RU2322978C2 |
| APPLICATION OF METHYL NALTREXONE FOR TREATING IRRITABLE COLON SYNDROME | 2004 |
|
RU2373936C2 |
| 5-HT RECEPTOR AGONIST COMPOUNDS FOR TREATING COGNITIVE DISORDERS | 2010 |
|
RU2569056C2 |
| METHODS AND COMPOSITIONS FOR TREATING HYPERHIDROSIS | 2016 |
|
RU2718906C2 |
| COMPOSITIONS OF PILL WITH IMMEDIATE RELEASE | 2010 |
|
RU2558798C2 |
| NOVEL SALT FORM OF DOPAMINE AGONIST | 2006 |
|
RU2393153C2 |
| METHOD OF TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES AGAINST CALCITONIN GENE-RELATED PEPTIDE | 2010 |
|
RU2535074C2 |
| METHOD FOR PREVENTION ABUSE WITH OPIOID- -CONTAINING MEDICINAL FORMULATIONS | 1998 |
|
RU2228180C2 |
